tailored pharmacotherapyASCVDsepsiscoronary artery diseasepolyvascular diseaseatherosclerotic cardiovascular disease
…gement of sepsis and ASCVD—using targeted interventions such as tailored pharmacotherapy and risk factor modification—may reduce mortality and morbidity…